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Commentary
Research into cost and value 
in medical education: can we make 
findings more generalisable?
Medical education is expensive [1]. It is also impor-
tant. These two self-evident statements mean that if we 
could ensure that we achieve maximum value from our 
spend in medical education, then clear benefits would 
accrue to payers (be they individuals or institutions) 
[2]. This might mean cost savings or better value for a 
given spend. Cost and value in medical education has 
traditionally been an under-explored area, but in recent 
years a growing number of research articles and papers 
have started to appear in the literature [3, 4]. However 
many of the articles describe tactical projects within 
specific areas. As a result the generalisability of such 
articles is often questionable. Lack of generalisability 
will mean that progress in research and practice in this 
field will be slow. Generalisability of cost-value analyses 
in any discipline is not always straightforward. However 
it may be that medical education research can learn 
from medical research - certainly cost-value analyses in 
medicine have been around for longer and are therefore 
much more mature. So what makes for generalisability 
in research in cost analyses in general medical research? 
Drummond et al. have made a number of recom-
mendations to improve the generalisability of economic 
evaluations when conducted alongside randomised tri-
als [5]. They recommend that researchers ensure abso-
lute clarity in their reports with regard to study centres, 
enrolment of patients, alternative treatments, perspec-
tives of stakeholders, resources used and their costs, in-
struments used, variability, and any problems with the 
analyses (such as incomplete data) [5]. All these ele-
ments “work” in the context of cost analysis in medical 
research - however the question remains of the practi-
cality of applying them to medical education economic 
analyses. Let’s take them one by one. 
With regard to study centres, most medical education 
research is carried out in medical schools or postgradu-
ate medical education institutions. Such institutions 
can be easily described and the results should then be 
more easily understood and generalised. If research is 
carried out in more than one institution, then all par-
ticipating institutions should be described. Most medi-
cal education research is carried out in single institu-
tions - this makes understanding the context simpler, 
but misses out on both the complexity and richness of 
multi-institutional research. That aside, medical educa-
tion economic analysts could easily be explicit about 
the institutions where research is being carried out, and 
this should facilitate generalisability. 
Medical researchers concern themselves with enrol-
ment of patients, but medical education researchers 
think about enrolment of learners. Ideally learners will 
be representative of their peers outside of the research 
- this will enable more straightforward generalisation. 
If however the research inclusion criteria exclude large 
numbers of learners, this will be a threat to generalisa-
tion. Regardless of whether learners were excluded or 
not, it is most important that the reporting is clear and 
explicit about who was included and excluded and why. 
If the medical education economic analysis compared 
the cost and value of a new innovation compared to an 
alternative form of education, then the reporting should 
make clear exactly what the alternative was. Vague 
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descriptions have no place in rigorous cost and value 
analyses. All too often the medical education literature 
refers to traditional medical education, but what is tra-
ditional will vary between time and geographical set-
ting. What was innovative thirty years ago may be tradi-
tional now. Innovation in one territory may be standard 
practice in another. Problem-based learning (PBL) is a 
classic case in point. Can we really say that it is still in-
novative? Maybe in a diminishing number of territories. 
This is not to praise or damn or damn with faint praise 
PBL but rather a statement about its dissemination. 
David Prideaux has captured this well: “problem based 
learning, an educational intervention characterised by 
small group and self directed learning, is one of medi-
cal education’s more recent success stories, at least in 
terms of its ubiquity” [6].
Relevant stakeholder perspective is also as impor-
tant in medical education research as it is in medical 
research. The cost and value of medical education in-
terventions will appear differently when examined from 
diff perspectives. For example the perspective of a uni-
versity department may be different to that of a govern-
ment which in turn may be different to that of a medi-
cal student. For example the government might want 
to save money, the university department might want 
to spend it and the student might just want a grant or 
a low interest loan. It is best to be clear from which or 
whose perspective a cost analysis is being portrayed - 
this will help the reader gain a deeper understanding 
and perhaps to contextualise the results in the perspec-
tives of stakeholders that are important in their own 
territory. 
When medical researchers describe resources used 
and their costs, they are typically describing drugs or 
procedures and the costs or tariffs with which they are 
associated. Economists advise separate descriptions of 
resources and costs. The parallels in medical education 
research might be tutor time or simulation equipment 
and their associated costs. In cost-value medical educa-
tion research it is best to separate these also. The reason 
is that customary practice may be different in the coun-
try of the reader to that of the researcher. Prices may 
also be different. However if the author is clear about 
the quantity of resources used and their cost, the reader 
will be able to extrapolate this data to their own coun-
try - with its particular customary practices and prices. 
Just as medical researchers use external, validated 
and international instruments to report health out-
comes, so medical educational researchers should use 
external, validated and international instruments to re-
port educational outcomes. The reader of the research 
will then be able to quickly evaluate whether the educa-
tional outcomes reported are relevant and applicable to 
their institution’s circumstances.     
Variability in cost and value analysis in medical re-
search generally means variability by location in the 
context of multicentre trials. This is less likely to be a 
problem in medical education cost and value analyses – 
most of which are single centre. 
Problems with the data can be manifold. There may 
be uneven baseline demographics among learners at the 
start, over-emphasis on subgroup analyses in the middle 
and/or incomplete follow up at the end.  
Economic evaluations of in medical education may 
not always be seamlessly transferable from one context 
to another. However if researchers consider these ele-
ments when carrying out their evaluations and reporting 
on them, readers will be more likely to be able to tell if 
the findings are generalisable to their own setting. If the 
findings are not exactly generalisable, they will likely know 
how the findings might need to be contextualised to make 
them fit with their requirements and their setting.
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